Cancer Treatment using Hyperthermia!
What is hyperthermia?
Hyperthermia (also called thermal therapy or thermotherapy) is a type of cancer treatment in which body tissue is exposed to high temperatures (up to 41 degrees celsius). Research has shown that high temperatures can damage and kill cancer cells, usually with minimal injury to normal tissues. By killing cancer cells and damaging proteins and structures within cells, hyperthermia may shrink tumors.
Hyperthermia is almost always used with other forms of cancer therapy.
- In local hyperthermia, heat is applied to a small area, such as a tumor, using various techniques that deliver energy to heat the tumor. Different types of energy may be used to apply heat, including microwave, radiofrequency, and ultrasound. Depending on the tumor location, there are several approaches to local hyperthermia:
- In regional hyperthermia, various approaches may be used to heat large areas of tissue, such as a body cavity, organ, or limb.
- Whole-body hyperthermia is used to treat metastatic cancer that has spread throughout the body. This can be accomplished by several techniques that raise the body temperature to 107–108°F, including the use of thermal chambers (similar to large incubators) or hot water blankets.
The effectiveness of hyperthermia treatment is related to the temperature achieved during the treatment, as well as the length of treatment and cell and tissue characteristics. To ensure that the desired temperature is reached, but not exceeded, the temperature of the tumor and surrounding tissue is monitored throughout hyperthermia treatment.
The Cocoon Wellness Pro is a personalized sauna, detox, and weight loss system designed for full body comfort and relaxation. The Cocoon POD includes both infrared (IR) and traditional dry (sauna) heat features
Unique to the sauna industry, SaunaWellness Sauna IR-PRO includes tri-spectrum infrared (IR) heating. This unique system allows the you to experience the benefits of three separate wavelengths for fast and even heating.
FAR Infrared Sauna
Our bodies have many ways of ridding itself from toxins and free radicals that build up. One of these ways is through natural sweating. A FAR infrared sauna penetrates the body and raises the body’s core temperature, which in turn promotes more sweat to be formed. Because of the penetration of the infrared technology, the sweat contains more toxins than one would sweat out in a traditional hot rock or wet sauna.
What can I expect from a FAR infrared sauna session and what will it do for me?
- Patients who go for Far infrared sauna sessions often experience deep relaxation during and after a treatment
- FAR infrared sauna is an excellent addition to most treatments
Patients often report better sleeping patterns after sessions
Who can get FAR infrared
FAR infrared sauna is available to anybody except pregnant women and children under five. Always check with your healthcare provider before starting FAR infrared sauna therapy.
How long does it take?
A standard session of far infrared sauna takes between 35 and 45 minutes.
- van der Zee J. Heating the patient: A promising approach? Annals of Oncology 2002; 13:1173–1184.
- Hildebrandt B, Wust P, Ahlers O, et al. The cellular and molecular basis of hyperthermia. Critical Reviews in Oncology/Hematology 2002; 43:33–56.
- Wust P, Hildebrandt B, Sreenivasa G, et al. Hyperthermia in combined treatment of cancer. The Lancet Oncology 2002; 3:487–497.
- Alexander HR. Isolation perfusion. In: DeVita VT Jr., Hellman S, Rosenberg SA, editors. Cancer: Principles and Practice of Oncology. Vol. 1 and 2. 6th ed. Philadelphia: Lippincott Williams and Wilkins, 2001.
- Falk MH, Issels RD. Hyperthermia in oncology. International Journal of Hyperthermia 2001; 17(1):1–18.
- Dewhirst MW, Gibbs FA Jr, Roemer RB, Samulski TV. Hyperthermia. In: Gunderson LL, Tepper JE, editors. Clinical Radiation Oncology. 1st ed. New York, NY: Churchill Livingstone, 2000.
- Kapp DS, Hahn GM, Carlson RW. Principles of Hyperthermia. In: Bast RC Jr., Kufe DW, Pollock RE, et al., editors. Cancer Medicine e.5. 5th ed. Hamilton, Ontario: B.C. Decker Inc., 2000.
- Feldman AL, Libutti SK, Pingpank JF, et al. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. Journal of Clinical Oncology 2003; 21(24):4560–4567.
- Chang E, Alexander HR, Libutti SK, et al. Laparoscopic continuous hyperthermic peritoneal perfusion. Journal of the American College of Surgeons 2001; 193(2):225–229.